Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles

This publication has 18 references indexed in Scilit:

• Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction
  Human Reproduction, 2006
• GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis
  Human Reproduction Update, 2005
• A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
  Human Reproduction, 2005
• GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study
  Human Reproduction, 2005
• The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI
  Human Reproduction, 2004
• Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles
  Fertility and Sterility, 2004
• Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin
  Fertility and Sterility, 2003
• Pregnancies achieved after frozen–thawed pronuclear oocytes obtained by intracytoplasmic sperm injection with spermatozoa extracted from frozen–thawed testicular tissues from non-obstructive azoospermic men
  Human Reproduction, 1999
• Use of Gonadotropin-Releasing Hormone Agonist to Trigger Follicular Maturation for in Vitro Fertilization*
  Journal of Clinical Endocrinology & Metabolism, 1990
• Hormonal Dynamics at Midcycle: A Reevaluation*
  Journal of Clinical Endocrinology & Metabolism, 1983